Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.

The primary mechanism underlying pre-eclampsia (PE) remains one of the most burning problems in the obstetrics and gynecology. In this study, we performed an expression profiling screen and detected 1312 genes that were differentially expressed (p<0.05 and fold change >1.5) in PE placentas, in...

Full description

Bibliographic Details
Main Authors: Yuqian Xiang, Yan Cheng, Xiaotian Li, Qiaoli Li, Jiawei Xu, Junyu Zhang, Yun Liu, Qinghe Xing, Lei Wang, Lin He, Xinzhi Zhao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3609796?pdf=render
_version_ 1818356053524348928
author Yuqian Xiang
Yan Cheng
Xiaotian Li
Qiaoli Li
Jiawei Xu
Junyu Zhang
Yun Liu
Qinghe Xing
Lei Wang
Lin He
Xinzhi Zhao
author_facet Yuqian Xiang
Yan Cheng
Xiaotian Li
Qiaoli Li
Jiawei Xu
Junyu Zhang
Yun Liu
Qinghe Xing
Lei Wang
Lin He
Xinzhi Zhao
author_sort Yuqian Xiang
collection DOAJ
description The primary mechanism underlying pre-eclampsia (PE) remains one of the most burning problems in the obstetrics and gynecology. In this study, we performed an expression profiling screen and detected 1312 genes that were differentially expressed (p<0.05 and fold change >1.5) in PE placentas, including LEP and SH3PXD2A. After validating the microarray results, we conducted the quantitative methylation analysis of LEP and SH3PXD2A in preeclamptic (n = 16) versus normal placentas (n = 16). Our results showed that many CpG sites close to the transcriptional start site (TSS) of LEP gene were hypomethylated in placentas from pregnancies with PE compared with those of in controls, including the TSS position (p = 0.001), the binding sites of Sp1 (p = 1.57×10(-4)), LP1 (p = 0.023) and CEBPα (p = 0.031). Luciferase reporter analysis confirmed the aberrant methylation of LEP promoter and CEBPα co-transfection had a role in the regulation of gene expression. Our results indicated the aberrant LEP promoter methylation was involved in the development of PE. We did not find a significant methylation differences between groups in the promoter region of SH3PXD2A, however, a CGI region in the gene body (CGI34) presented a higher methylation in preeclamptic placentas (p = 1.57×10(-4)), which might promote the efficiency of gene transcription. We speculated that SH3PXD2A may take part in the pathogenesis of PE through its role in the regulation of trophoblast cell invasion in the period of placenta formation.
first_indexed 2024-12-13T19:51:06Z
format Article
id doaj.art-e06d4c64ce5649bc82bd0b614cc03feb
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T19:51:06Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e06d4c64ce5649bc82bd0b614cc03feb2022-12-21T23:33:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5975310.1371/journal.pone.0059753Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.Yuqian XiangYan ChengXiaotian LiQiaoli LiJiawei XuJunyu ZhangYun LiuQinghe XingLei WangLin HeXinzhi ZhaoThe primary mechanism underlying pre-eclampsia (PE) remains one of the most burning problems in the obstetrics and gynecology. In this study, we performed an expression profiling screen and detected 1312 genes that were differentially expressed (p<0.05 and fold change >1.5) in PE placentas, including LEP and SH3PXD2A. After validating the microarray results, we conducted the quantitative methylation analysis of LEP and SH3PXD2A in preeclamptic (n = 16) versus normal placentas (n = 16). Our results showed that many CpG sites close to the transcriptional start site (TSS) of LEP gene were hypomethylated in placentas from pregnancies with PE compared with those of in controls, including the TSS position (p = 0.001), the binding sites of Sp1 (p = 1.57×10(-4)), LP1 (p = 0.023) and CEBPα (p = 0.031). Luciferase reporter analysis confirmed the aberrant methylation of LEP promoter and CEBPα co-transfection had a role in the regulation of gene expression. Our results indicated the aberrant LEP promoter methylation was involved in the development of PE. We did not find a significant methylation differences between groups in the promoter region of SH3PXD2A, however, a CGI region in the gene body (CGI34) presented a higher methylation in preeclamptic placentas (p = 1.57×10(-4)), which might promote the efficiency of gene transcription. We speculated that SH3PXD2A may take part in the pathogenesis of PE through its role in the regulation of trophoblast cell invasion in the period of placenta formation.http://europepmc.org/articles/PMC3609796?pdf=render
spellingShingle Yuqian Xiang
Yan Cheng
Xiaotian Li
Qiaoli Li
Jiawei Xu
Junyu Zhang
Yun Liu
Qinghe Xing
Lei Wang
Lin He
Xinzhi Zhao
Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
PLoS ONE
title Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
title_full Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
title_fullStr Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
title_full_unstemmed Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
title_short Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
title_sort up regulated expression and aberrant dna methylation of lep and sh3pxd2a in pre eclampsia
url http://europepmc.org/articles/PMC3609796?pdf=render
work_keys_str_mv AT yuqianxiang upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT yancheng upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT xiaotianli upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT qiaolili upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT jiaweixu upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT junyuzhang upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT yunliu upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT qinghexing upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT leiwang upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT linhe upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia
AT xinzhizhao upregulatedexpressionandaberrantdnamethylationoflepandsh3pxd2ainpreeclampsia